Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2020-12-02 Capital/Financing Update
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) notifying them of the schedule of investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events or information. The content is about informing the exchanges and public about upcoming investor meetings, which is a type of Capital/Financing Update or investor relations activity. The document is short (1556 characters) and does not contain financial statements or detailed financial data. It is not an earnings release or annual report, nor is it a regulatory filing or certification. The best fitting category is Capital/Financing Update (CAP) as it relates to investor meetings and disclosures under SEBI regulations.
2020-12-02 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the publication of newspaper advertisements about the transfer of shares to the Investor Education and Protection Fund (IEPF). It includes mention of newspaper cuttings as enclosures and is signed by the company secretary. The document is short (1281 characters) and does not contain any financial data, report content, or detailed disclosures. It is an announcement related to share transfer information for regulatory record-keeping. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2020-11-25 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter dated 25th November 2020 from Torrent Pharmaceuticals Limited addressed to BSE Limited. It informs about the issuance of duplicate share certificates pursuant to SEBI regulations. The content is a notification about share certificate issuance, not a financial report, management change, or voting result. It does not contain financial data or detailed report content. The document is short (1499 characters) and serves as an official announcement of a corporate action related to shares. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-11-25 English
Newspaper Advertisement In Respect Of transfer of shares to IEPF
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the publication of newspaper advertisements about the transfer of shares to the Investor Education and Protection Fund (IEPF). It includes mention of newspaper cuttings as enclosures and is signed by the company secretary. The document is short (1281 characters) and does not contain any financial data, report content, or detailed disclosures. It is an announcement related to share transfer information for regulatory record-keeping. This fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2020-11-25 English
Intimation of Issue of Duplicate Share Certificate
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing about the issuance of duplicate share certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management and shareholder records. The content is a formal notification about share certificate issuance, not a financial report, earnings release, or management discussion. It does not contain financial data or results, nor does it announce voting results or capital changes like new share issues or buybacks. The document is a regulatory announcement related to share certificates, which fits best under Regulatory Filings (RNS) as it is a compliance disclosure to the stock exchanges without fitting other specific categories.
2020-11-25 English
Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short letter dated November 21, 2020, addressed to the stock exchange listing department, informing about the schedule of an investor meeting (Ambit Capital Healthcare Conclave) on November 23, 2020. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of an upcoming investor meeting, not a report or transcript of the meeting itself. The document length is only 1407 characters, indicating it is a brief notice rather than a detailed report or transcript. Therefore, this fits the category of an Investor Presentation announcement or schedule notice. However, since it is only an intimation of the schedule of an investor meet and not the presentation itself, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and disclosures that do not fit other categories.
2020-11-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.